Research and development for army phase II sbir month 1-24 project titled, developing an ideal first use agent to prevent sepsis in trauma wounds during care under fire
Active Definitive Contract Awarded Last action
- Contract number
- W81XWH22C0045
- Awardee
-
Altrazeal Life Sciences Inc. UEI N24WUMUHT5V9
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,155,968
Award facts
- Opportunity
-
- HQ003420R2ADB Solicitation number
- Contract value 100% obligated
- $1,155,968.00 Current and potential, with all options
- Completion date 95% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Addison, TX 75001, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,155,968 |
About this award
The Defense Health Agency awarded a $1,155,968 definitive contract to Altrazeal Life Sciences Inc. for Phase II SBIR research and development on September 6, 2022, under a total small business set-aside.
The contract funds research and development over months 1–24 for developing an ideal first-use agent to prevent sepsis in trauma wounds during care under fire. Work is performed in Addison, Texas. The contract is firm fixed price with an ultimate completion date of January 5, 2027.
Quick answers
Who was awarded contract W81XWH22C0045?
W81XWH22C0045 was awarded to Altrazeal Life Sciences Inc. by Defense Health Agency (Department of Defense) on September 6, 2022.
How much is contract W81XWH22C0045 worth?
The government has obligated $1,155,968 on W81XWH22C0045.
Was contract W81XWH22C0045 competed?
The extent of competition for W81XWH22C0045 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award